Test Lists

  • Regression Package Testing List Page
Publisher QA3 - UPP Test
  • Regression Package Testing List Page
1 / 0

Infoblox’s BloxOne Threat Defense Catches Security Blindspots Missed by the Competition

November 4, 2020
By Infoblox Inc.
Alt Text FF - Home Screen Icon 3
Caption FF
Description FF
Share this...
  • Facebook
  • Pinterest
  • Twitter
  • Linkedin

SANTA CLARA, Calif., Nov. 4, 2020 /PRNewswire/ — Infoblox Inc., the leader in Secure Cloud-Managed Network Services, today announced the results of a Tolly Group test that found the BloxOne Threat Defense secure DNS solution is more secure and effective than the competition. BloxOne Threat Defense also provides more threat intelligence integrations, leading to easier threat hunting than the competing solution.

Tolly tested BloxOne Threat Defense and a competitor across real-world scenarios and recorded the results for each. The results showed that BloxOne Threat Defense:

  • Blocked DNS-based data exfiltration attacks better, as well as the exfiltration of credit card data from point-of-sale (PoS) terminals. While the other solution was only able to block hard-coded versions of DNS attacks and failed to detect the exfiltration of credit card data;
  • Blocked 6 zero day local specific phishing sites that the other solution missed;
  • More effectively prevented malware from being installed, by blocking access to malicious servers, and detecting and stopping the infiltration of malicious data via DNS better than competition;
  • Made threat response teams more effective with a more intuitive user interface, more useful threat indicators, greater context on threats, and a broader ecosystem with which it can integrate and share threat intelligence.

“DNS is a powerful tool for protecting an organization’s network and should be a critical part of any organization’s cybersecurity strategy,” says Craig Sanderson, Vice President of Security Products, Infoblox. “The accelerating shift to the cloud is driving organizations to adopt solutions that respond to the security challenges posed by hybrid, multi-cloud networks. As malicious actors evolve their use of DNS, as we saw in the healthcare ransomware attacks that CISA highlighted, organizations need more context aware security and automation to keep up.”

“With its superior ease of use, richer threat intelligence, and greater integrations with other security products, BloxOne Threat Defense is the clear choice for providing foundational protection to the modern workforce, wherever they are located,” Sanderson explained. “The results validate our work delivering security that’s simple to use and effective from Day Zero.”

To conduct the study, Tolly created several scenarios that replicated real-world situations including a PoS terminal infected with malware, malware infiltration and an attempted data exfiltration over DNS, which would typically occur after infection. They then compared how BloxOne Threat Defense and the competing solution performed across a number of variables. BloxOne Threat Defense stood out for its ability to not only detect and block these attacks, but to provide fuller visibility into the network environment, deliver greater contextual data to security teams, and automate the sharing of actionable intelligence through its many ecosystem integrations, making incident detection and response more effective, efficient, and comprehensive.

About Infoblox
Infoblox delivers the next level network experience with its Secure Cloud-Managed Network Services. As the pioneer in providing the world’s most reliable, secure and automated networks, we are relentless in our pursuit of next level network simplicity. A recognized industry leader, Infoblox has more than 8,000 customers, including 350 of the Fortune 500.

Learn more at https://www.infoblox.com

Media Contact
Lise Feng
lise@infoblox.com

Categories: Madison Magazine Logo

Latest Stories

Eu Regulator Authorizes Astrazeneca Vaccine For All Adults

EU regulator authorizes AstraZeneca vaccine for all adults

Rayos Syndication User,
KXLY-Latest Stories

Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.

Ex Fbi Lawyer Given Probation For Russia Probe Actions

Ex-FBI lawyer given probation for Russia probe actions

Rayos Syndication User,
KXLY-Latest Stories

WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.

Evers: Repealing Mask Mandate Like Eliminating Speed Limits

Evers: Repealing mask mandate like eliminating speed limits

Rayos Syndication User,
KXLY-Latest Stories

MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.

Conservatives Praise South Carolina Win On Abortion Ban

Conservatives praise South Carolina win on abortion ban

Rayos Syndication User,
KXLY-Latest Stories

COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.

Moscow Court Puts Navalny’s Allies Under House Arrest

Moscow court puts Navalny's allies under house arrest

Rayos Syndication User,
KXLY-Latest Stories

A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.

Most Popular

9:40 Future Import Test

One more current test NW

Current UPP Import NW

Test New Article 12092025 - 4 - Message

Test New Article 12092025 - 4 - Election

Test New Article 12092025 - 2 - Closing

© 2026 Publisher QA3 – UPP Test.

Privacy Policy
Powered byBLOX Digital
X